
Thursday, June 26 8:30–9:30am
Brain Check: Promoting Brain Health and Detecting Cognitive Impairment

Thursday, June 26 1:30–2:30pm
Skin Deep: Tackling Everyday Dermatologic Cases in Primary Care

Thursday, June 26 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity

Thursday, June 26 8:30–9:30am
Brain Check: Promoting Brain Health and Detecting Cognitive Impairment
Thursday, June 26 10:30–11:30am

Thursday, June 26 3:30–4:15pm
Breakthroughs in Psychiatry: Emerging Treatments for Common Disorders

Thursday, June 26 7:30–8:30am
Thursday, June 26 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity

Friday, June 27 1:30–2:30pm
Cardiology in Focus: Breaking Down the Latest Guideline Updates
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Andrew E. Budson, MD
- Advisor: Eli Lilly and AbbVie; Independent Contractor: Vox Neuro and Bristol Meyers Squibb
- Stephen N. Henry, DO, MS
- No relevant financial relationships disclosed.
- Jennifer A. Johnson, MD
- No relevant financial relationships disclosed.
- Pamela Kushner, MD, FAAFP
- Advisor: GlaxoSmithKline, Novo Nordisk, AstraZeneca, Lilly, Abbott, Haleon, Bausch/SALIX, Corcept, Boehringer Ingelheim; Speaker: Novo Nordisk, Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Abbott, Phathom, Bausch/SALIX, Intuity, Pfizer, and Janssen.
- Avery Lachance, MD, MPH
- Consultant: Guidepoint, J&J, Pfizer; Researcher: Merck, Pfizer; Advisor: TD Cowen
- Joynita R. Nicholson, DO, DABOM, FOMA
- No relevant financial relationships disclosed.
- Vani Potluri, MD
- No relevant financial relationships disclosed
- Jeffrey Rado, MD, MPH, FAPA
- Speaker: Alkermes; Researcher: Cerevel, Neurorelief, NRX Pharmaceuticals; Consultant: Paraxel
- Philip Schoenfeld, MD, MSEd, MSc
- Speaker: Ironwood Pharmaceuticals, Ardelyx Pharmaceuticals, Phathom Pharmaceuticals, AbbVie Pharmaceuticals; Consultant: Phathom Pharmaceuticals, Ardelyx Pharmaceuticals
- Chrisandra L. Shufelt, MD, MS, FACP, MSCP
- Advisor: Bayer, Novo Nordisk
- Charles Vega, MD, FAAFP
- Consultant: Boehringer Ingelheim, and Exact Sciences
- Karol E. Watson, MD, PhD
- Consultant: Amarin, Amgen, Boehringer Ingelheim, Eli Lilly, Novartis
- Gloria Y. Yeh, MD, MPH
- No relevant financial relationships disclosed.
Other Disclosures
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.